Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. Total Liabilities 2016–2025
Collegium Pharmaceutical Inc. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Collegium Pharmaceutical Inc. total liabilities as of December 31, 2025: 1.36B, a 5.55% decrease year-over-year.
- Collegium Pharmaceutical Inc. total liabilities for 2025 were 1.36B, a 5.55% decrease from 2024.
- Collegium Pharmaceutical Inc. total liabilities for 2024 were 1.43B, a 51.36% increase from 2023.
- Collegium Pharmaceutical Inc. total liabilities for 2023 were 947.9M, a 3.21% decrease from 2022.
- Collegium Pharmaceutical Inc. total liabilities for 2022 were 979.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Collegium Pharmaceutical Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,355 |
| 2024 | $1,435 |
| 2023 | $948 |
| 2022 | $979 |
| 2021 | $489 |
| 2020 | $458 |
| 2019 | $219 |
| 2018 | $200 |
| 2017 | $31 |
| 2016 | $27 |
Collegium Pharmaceutical Inc. Total Liabilities — FAQ
Collegium Pharmaceutical Inc. (COLL) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COLL's total liabilities history?
The chart and table above show Collegium Pharmaceutical Inc.'s total liabilities by year and by quarter, including the growth rate.